| 5-HT | 5-hydroxytryptamine |
| BBB | blood–brain barrier |
| BDNF | brain-derived neurotrophic factor |
| Ccl2 | C-C motif chemokine ligand 2 |
| D2R | D2 dopamine receptor |
| D3R | D3 dopamine receptor |
| DAT | dopamine transporter |
| FDA | Food and Drug Administration |
| GABA | γ-aminobutyric acid |
| GABA-AT | GABA aminotransferase |
| GDNF | glial cell line-derived neurotrophic factor |
| H3Q5dop | histone H3 glutamine 5 dopaminylation |
| KOR | kappa opioid receptor |
| NAc | nucleus accumbens |
| NMDA | N-methyl-D-aspartic acid |
| NMDAR | NMDA receptor |
| PET | positron emission tomography |
| PPAR | peroxisome proliferator-activated receptor |
| ROCK | Rho-associated protein kinase |
| SERT | serotonin transporter |
| TBG | tabernanthalog |
| TNF-α | tumor necrosis factor-α |
| VRAC | volume-regulated anion channel |
| VTA | ventral tegmental area |